The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 25, 2019
Filed:
Sep. 19, 2016
Applicant:
Universite DE Montreal, Montreal, Quebec, CA;
Inventors:
Alain Martel, Montreal, CA;
Francois Tremblay, Montreal, CA;
Assignee:
Universite de Montreal, Montreal, QC, CA;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 513/04 (2006.01); C07D 487/04 (2006.01); C07D 498/04 (2006.01); A61P 7/02 (2006.01); A61K 31/433 (2006.01); A61K 31/454 (2006.01); A61K 31/4545 (2006.01); A61K 31/496 (2006.01);
U.S. Cl.
CPC ...
C07D 513/04 (2013.01); A61K 31/433 (2013.01); A61K 31/454 (2013.01); A61K 31/4545 (2013.01); A61K 31/496 (2013.01); A61P 7/02 (2018.01); C07D 487/04 (2013.01); C07D 498/04 (2013.01);
Abstract
The present invention provides compounds of Formula I: wherein Y, AA, W, RR, R, R, R, R, X, X, X, Xand Xare as defined herein, or a stereoisomer, tautomer, pharmaceutically acceptable salt, prodrug or esters or solvate form thereof, wherein all of the variables are as defined herein. These compounds are inhibitors of platelet aggregation and thus can be used as medicaments for treating or preventing thromboembolic disorders.